Seroclearance rate of hepatitis B surface antigen in 2,112 patients with chronic hepatitis in Japan during long-term follow-up. (Q51217648)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23783839%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

title

Seroclearance rate of hepatitis B surface antigen in 2,112 patients with chronic hepatitis in Japan during long-term follow-up (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23783839%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23783839%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

13

Hiromitsu Kumada

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23783839%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

3

Fumitaka Suzuki

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23783839%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

11

Kenji Ikeda

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23783839%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

8

Masahiro Kobayashi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23783839%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

6

Yoshiyuki Suzuki

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23783839%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

4

Norio Akuta

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23783839%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

10

Yasuji Arase

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23783839%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

5

Hitomi Sezaki

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23783839%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

9

Satoshi Saitoh

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23783839%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

7

Yusuke Kawamura

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23783839%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

1

Mariko Kobayashi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23783839%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

author name string

Yuzo Miyakawa

series ordinal

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23783839%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

publication date

20 June 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23783839%20AND%20SRC:MED&resulttype=core&format=json

Journal of Gastroenterology

3 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23783839%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

volume

49

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23783839%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23783839%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

page(s)

538-546

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23783839%20AND%20SRC:MED&resulttype=core&format=json

Hepatitis B virus infection--natural history and clinical consequences

3 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0821-2

Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0821-2

Sero-clearance of hepatitis B surface antigen in chronic carriers does not necessarily imply a good prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0821-2

Predicting cirrhosis risk based on the level of circulating hepatitis B viral load

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0821-2

Prognosis following spontaneous HBsAg seroclearance in chronic hepatitis B patients with or without concurrent infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0821-2

HBsAg Seroclearance in chronic hepatitis B in Asian patients: replicative level and risk of hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0821-2

Long-term efficacy of interferon therapy in patients with chronic hepatitis B virus infection in Japan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0821-2

Favorable efficacy of long-term lamivudine therapy in patients with chronic hepatitis B: an 8-year follow-up study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0821-2

Clearance of hepatitis B surface antigen during long-term nucleot(s)ide analog treatment in chronic hepatitis B: results from a nine-year longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0821-2

Long-term clinical and histological outcomes in patients with spontaneous hepatitis B surface antigen seroclearance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0821-2

Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0821-2

Incidence and determinants of spontaneous hepatitis B surface antigen seroclearance: a community-based follow-up study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0821-2

Spontaneous loss of hepatitis B surface antigen in chronic carriers, based on a long-term follow-up study in Goto Islands, Japan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0821-2

Serologic and clinical outcomes of 1536 Alaska Natives chronically infected with hepatitis B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-013-0821-2

Hepatitis B virus infection

21 January 2018

1 reference

12 December 2020

Long-term outcome after hepatitis B surface antigen seroclearance in patients with chronic hepatitis B.

1 reference

12 December 2020

Factors associated with natural seroclearance of hepatitis B surface antigen and prognosis after seroclearance: a prospective follow-up study

1 reference

12 December 2020

Acute hepatitis B in infants born to carrier mother with the antibody to hepatitis B e antigen

1 reference

12 December 2020

Loss of hepatitis B surface antigen from the serum of patients with chronic hepatitis treated with lamivudine

1 reference

12 December 2020

HBsAg seroclearance in asymptomatic carriers of high endemic areas: appreciably high rates during a long-term follow-up

1 reference

12 December 2020

Clearance of hepatitis B surface antigen and risk of hepatocellular carcinoma in a cohort chronically infected with hepatitis B virus

1 reference

12 December 2020

10.1007/S00535-013-0821-2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23783839%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

1 reference